1. Home
  2. SABS vs BLBX Comparison

SABS vs BLBX Comparison

Compare SABS & BLBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • BLBX
  • Stock Information
  • Founded
  • SABS 2014
  • BLBX 2014
  • Country
  • SABS United States
  • BLBX United States
  • Employees
  • SABS N/A
  • BLBX N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • BLBX EDP Services
  • Sector
  • SABS Health Care
  • BLBX Technology
  • Exchange
  • SABS Nasdaq
  • BLBX Nasdaq
  • Market Cap
  • SABS 11.4M
  • BLBX 10.6M
  • IPO Year
  • SABS N/A
  • BLBX N/A
  • Fundamental
  • Price
  • SABS $1.75
  • BLBX $3.25
  • Analyst Decision
  • SABS Strong Buy
  • BLBX
  • Analyst Count
  • SABS 5
  • BLBX 0
  • Target Price
  • SABS $11.40
  • BLBX N/A
  • AVG Volume (30 Days)
  • SABS 25.4K
  • BLBX 47.9K
  • Earning Date
  • SABS 05-19-2025
  • BLBX 05-14-2025
  • Dividend Yield
  • SABS N/A
  • BLBX N/A
  • EPS Growth
  • SABS N/A
  • BLBX N/A
  • EPS
  • SABS N/A
  • BLBX N/A
  • Revenue
  • SABS $1,322,410.00
  • BLBX $2,566,946.00
  • Revenue This Year
  • SABS N/A
  • BLBX N/A
  • Revenue Next Year
  • SABS $50.00
  • BLBX N/A
  • P/E Ratio
  • SABS N/A
  • BLBX N/A
  • Revenue Growth
  • SABS N/A
  • BLBX N/A
  • 52 Week Low
  • SABS $1.00
  • BLBX $1.51
  • 52 Week High
  • SABS $5.01
  • BLBX $6.00
  • Technical
  • Relative Strength Index (RSI)
  • SABS 63.35
  • BLBX 51.47
  • Support Level
  • SABS $1.30
  • BLBX $2.82
  • Resistance Level
  • SABS $1.49
  • BLBX $3.44
  • Average True Range (ATR)
  • SABS 0.14
  • BLBX 0.25
  • MACD
  • SABS 0.06
  • BLBX 0.02
  • Stochastic Oscillator
  • SABS 100.00
  • BLBX 82.14

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About BLBX Blackboxstocks Inc.

Blackboxstocks Inc is a financial technology and social media hybrid platform offering real-time proprietary analytics and news for stock and options traders of all levels. Its web-based software (the Blackbox System) employs predictive technology enhanced by artificial intelligence to find volatility and unusual market activity that may result in a rapid change in the price of a stock or option. It provides users with a fully interactive social media platform that is integrated into its dashboard, enabling users to exchange information and ideas quickly and efficiently through a common network. The company introduced a live audio/video feature that allows members to broadcast on their channels to share trading strategies and market insight within the Blackbox community.

Share on Social Networks: